CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $171,719 | +145.3% | 29,404 | +182.4% | 0.00% | – |
| Q3 2022 | $70,000 | +25.0% | 10,412 | -37.4% | 0.00% | – |
| Q1 2022 | $56,000 | -49.5% | 16,627 | -37.0% | 0.00% | – |
| Q2 2021 | $111,000 | -31.9% | 26,404 | +58.6% | 0.00% | – |
| Q3 2020 | $163,000 | -63.9% | 16,647 | -4.4% | 0.00% | -100.0% |
| Q4 2017 | $451,000 | +46.4% | 17,421 | -14.3% | 0.00% | -50.0% |
| Q1 2015 | $308,000 | – | 20,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |